Assessment of human abuse potential of dasotraline compared to methylphenidate and placebo in recreational stimulant users - Koblan KS, Hopkins SC, Sarma K, Gallina N, Jin F, Levy-Cooperman N, Schoedel KA, Loebel A.

AIMS: The aim of this study was to evaluate the abuse potential of dasotraline, a novel dopamine and norepinephrine reuptake inhibitor with slow absorption (tmax, 10-12h) and elimination (t1/2=47-77h) that is in development for the treatment of attention d...
Source: SafetyLit - Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news